Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Altai

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|September 13, 2013
Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicineMohamed Altai, Anna Orlova, Vladimir Tolmachev
Molecules (Basel, Switzerland)|June 13, 2020
Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody MoleculesJavad Garousi, Anzhelika Vorobyeva, Mohamed Altai
International Journal of Oncology|August 31, 2016
Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxinMohamed Altai, Hao Liu, Anna Orlova, et al.
American Journal of Nuclear Medicine and Molecular Imaging|July 17, 2023
Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [<sup>177</sup>Lu]Lu-PSMA-617 therapy in an animal model of prostate cancerAyman Abouzayed, Wahed Zedan, Mohamed Altai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017
Pretargeted Imaging and TherapyMohamed Altai, Rosemery Membreno, Brendon Cook, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2020
Preparation of Conjugates for Affibody-Based PNA-Mediated PretargetingMohamed Altai, Anzhelika Vorobyeva, Vladimir Tolmachev, et al.
Journal of Medicinal Chemistry|April 29, 2011
Use of a HEHEHE purification tag instead of a hexahistidine tag improves biodistribution of affibody molecules site-specifically labeled with (99m)Tc, (111)In, and (125)ICamilla Hofstrom, Anna Orlova, Mohamed Altai, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 7, 2013
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumorsMohamed Altai, Zohreh Varasteh, Karl Andersson, et al.
Nuclear Medicine and Biology|August 16, 2017
Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and <sup>177</sup>Lu labelingMohamed Altai, Kristina Westerlund, Justin Velletta, et al.
EJNMMI Research|February 6, 2020
On the prevention of kidney uptake of radiolabeled DARPinsMohamed Altai, Javad Garousi, Sara S Rinne, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|September 13, 2013
Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicineMohamed Altai, Anna Orlova, Vladimir Tolmachev
Molecules (Basel, Switzerland)|June 13, 2020
Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody MoleculesJavad Garousi, Anzhelika Vorobyeva, Mohamed Altai
International Journal of Oncology|August 31, 2016
Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxinMohamed Altai, Hao Liu, Anna Orlova, et al.
American Journal of Nuclear Medicine and Molecular Imaging|July 17, 2023
Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [<sup>177</sup>Lu]Lu-PSMA-617 therapy in an animal model of prostate cancerAyman Abouzayed, Wahed Zedan, Mohamed Altai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017
Pretargeted Imaging and TherapyMohamed Altai, Rosemery Membreno, Brendon Cook, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2020
Preparation of Conjugates for Affibody-Based PNA-Mediated PretargetingMohamed Altai, Anzhelika Vorobyeva, Vladimir Tolmachev, et al.
Journal of Medicinal Chemistry|April 29, 2011
Use of a HEHEHE purification tag instead of a hexahistidine tag improves biodistribution of affibody molecules site-specifically labeled with (99m)Tc, (111)In, and (125)ICamilla Hofstrom, Anna Orlova, Mohamed Altai, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 7, 2013
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumorsMohamed Altai, Zohreh Varasteh, Karl Andersson, et al.
Nuclear Medicine and Biology|August 16, 2017
Evaluation of affibody molecule-based PNA-mediated radionuclide pretargeting: Development of an optimized conjugation protocol and <sup>177</sup>Lu labelingMohamed Altai, Kristina Westerlund, Justin Velletta, et al.
EJNMMI Research|February 6, 2020
On the prevention of kidney uptake of radiolabeled DARPinsMohamed Altai, Javad Garousi, Sara S Rinne, et al.
Pageof 7